Anavex Life Sciences Corp (AVXL)

[rayovacAAA]

FACTS ABOUT A2-73 P2B/3 TRIAL ENROLLMENT PROGRESS!!!!!!!!!:


1. 16 DECEMBER 2019 - NEARLY 50% RECRUITED!!!!!!!!


2. 28 DECEMBER 2020 - OVER 80% ENROLLED!!!!!!!!


3. 11 FEBRUARY 2021 - OVER 86% RECRUITED!!!!!!!!


4. 31 MARCH 2021 - OVER 92% ENROLLED!!!!!!!!


5. 13 MAY 2021 - “For our lead drug candidate, ANAVEX®2-73 in Alzheimer’s disease, we are close to complete enrollment for our Phase 2b/3 study"!!!!!!!!!


RECRUITED VS ENROLLED???????


DID MISSLING SAY OVER 98% RECRUITED OR ENROLLED, HMMMMMMMMMMMM!!!!!!!!


WE GO THIS!!!!!!!